Adelqui Peralta, MD
Adjunct Instructor, Medicine
Biography
Dr. Adelqui Peralta, MD is a clinical cardiac electrophysiologist in West Roxbury, MA. He graduated from Facultad De Medicina University Nat’l De Rosario and specializes in clinical cardiac electrophysiology.
Other Positions
- VA Boston Healthcare System
Education
- Facultad de Ciencias Médicas, MD
Publications
- Published on 8/7/2024
Qian X, Zei PC, Osorio J, Hincapie D, Gabr M, Peralta A, Miranda-Arboleda AF, Koplan BA, Hoyos C, Matos CD, Lopez-Cabanillas N, Steiger NA, Velasco A, Alviz I, Kapur S, Tadros TM, Tedrow UB, Sauer WH, Romero JE. Lesion characteristics using high-frequency low-tidal volume ventilation versus standard ventilation during ablation of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2024 Oct; 35(10):1962-1971. PMID: 39113311.
Read at: PubMed - Published on 4/10/2024
Backman WD, DiCaro MV, Zuo X, Peralta A, Orkaby AR. Aligning goals with care: Advance directives in older adults with implantable cardioverter-defibrillators. Pacing Clin Electrophysiol. 2024 May; 47(5):697-701. PMID: 38597183.
Read at: PubMed - Published on 2/13/2024
Kroshian G, Joseph J, Kinlay S, Peralta AO, Hoffmeister PS, Singh JP, Yuyun MF. Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2024 Apr; 35(4):715-726. PMID: 38348517.
Read at: PubMed - Published on 10/19/2023
Yuyun MF, Joseph J, Erqou SA, Kinlay S, Echouffo-Tcheugui JB, Peralta AO, Hoffmeister PS, Boden WE, Yarmohammadi H, Martin DT, Singh JP. Persistence of significant secondary mitral regurgitation post-cardiac resynchronization therapy and survival: a systematic review and meta-analysis : Mitral regurgitation and mortality post-CRT. Heart Fail Rev. 2024 Jan; 29(1):165-178. PMID: 37855988.
Read at: PubMed - Published on 1/22/2023
Diaz JC, Cañas F, Duque M, Aristizabal J, Niño C, Bastidas O, Marin J, Rivera E, Hoyos C, Matos C, Peralta A, Martin DT, Romero J. Assisted reality device to guide cardiac implantable device programming in distant rural areas. J Cardiovasc Electrophysiol. 2023 Mar; 34(3):497-501. PMID: 36640437.
Read at: PubMed - Published on 8/6/2021
Yuyun MF, Erqou SA, Peralta AO, Hoffmeister PS, Yarmohammadi H, Echouffo Tcheugui JB, Martin DT, Joseph J, Singh JP. Risk of ventricular arrhythmia in cardiac resynchronization therapy responders and super-responders: a systematic review and meta-analysis. Europace. 2021 08 06; 23(8):1262-1274. PMID: 33496319.
Read at: PubMed - Published on 2/6/2021
Yuyun MF, Erqou SA, Peralta AO, Hoffmeister PS, Yarmohammadi H, Echouffo-Tcheugui JB, Martin DT, Joseph J, Singh JP. Ongoing Risk of Ventricular Arrhythmias and All-Cause Mortality at Implantable Cardioverter Defibrillator Generator Change: A Systematic Review and Meta-Analysis. Circ Arrhythm Electrophysiol. 2021 03; 14(3):e009139. PMID: 33554611.
Read at: PubMed - Published on 5/12/2018
Ofman P, Hoffmeister P, Kaloupek DG, Gagnon DR, Peralta A, Djousse L, Gaziano JM, Rahilly-Tierney CR. Posttraumatic stress disorder and mortality in VA patients with implantable cardioverter-defibrillators. Clin Cardiol. 2018 May; 41(5):652-659. PMID: 29532498.
Read at: PubMed - Published on 6/30/2014
Ofman P, Petrone AB, Peralta A, Hoffmeister P, Albert CM, Djousse L, Gaziano JM, Rahilly-Tierney CR. Aspirin use and risk of atrial fibrillation in the Physicians' Health Study. J Am Heart Assoc. 2014 Jun 30; 3(4). PMID: 24980132.
Read at: PubMed - Published on 6/30/2013
Ofman P, Peralta A, Hoffmeister P, Gaziano JM, Djousse L. Do Omega-3 Fatty Acids Decrease the Incidence of Atrial Fibrillation? J Atr Fibrillation. 2013 Jun-Jul; 6(1):836. PMID: 28496856.
Read at: PubMed
View 6 more publications: View full profile at BUMC